Rahul Kakkar

Rahul Kakkar, John Finn, and Jorge Conde discuss PASTE, a genome editing technique that could make cell therapy more accessible. They explore advancements in genomic medicine, CRISPR technology, and focus on genetic diseases of the liver and autoimmune diseases. They also touch on challenges in transitioning from research to patients and share anecdotes about facial hair.

Guest Rahul Kakkar, President and CEO of Tome Biosciences, discusses AI lab partners, mRNA vaccines in Africa, and Moderna's cancer vaccine data.